-
1 Comment
Sonic Healthcare Limited is currently in a long term uptrend where the price is trading 8.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Sonic Healthcare Limited's total revenue sank by 0.0% to $2B since the same quarter in the previous year.
Its net income has dropped by 0.0% to $127M since the same quarter in the previous year.
Finally, its free cash flow grew by 67.0% to $333M since the same quarter in the previous year.
Based on the above factors, Sonic Healthcare Limited gets an overall score of 3/5.
Industry | Diagnostics & Research |
---|---|
Sector | Healthcare |
CurrencyCode | EUR |
Exchange | F |
ISIN | AU000000SHL7 |
PE Ratio | 17.56 |
---|---|
Target Price | None |
Beta | 0.52 |
Dividend Yield | 3.0% |
Market Cap | 11B |
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SAB.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024